BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 1376783)

  • 1. Renal hemodynamic effects of nonhypotensive doses of angiotensin-converting enzyme inhibitors in hypertension and heart failure rats.
    Nelissen-Vrancken HJ; Struijker-Boudier HA; Smits JF
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):163-8. PubMed ID: 1376783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graded regional vasodilation with converting enzyme inhibitors in conscious spontaneously hypertensive rats.
    Lappe RW; Todt JA; Wendt RL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):651-6. PubMed ID: 3001271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential systemic and regional hemodynamic profiles of four angiotensin-I converting-enzyme inhibitors in the rat.
    Richer C; Doussau MP; Giudicelli JF
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):865-72. PubMed ID: 2562138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
    Guidi E; Hollenberg NK
    J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional haemodynamic effects of captopril, enalaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro rats.
    Muller AF; Gardiner SM; Compton AM; Bennett T
    Clin Sci (Lond); 1990 Oct; 79(4):393-401. PubMed ID: 2171862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II/prostaglandin I2 interactions in spontaneously hypertensive rats.
    Jackson EK; Herzer WA
    Hypertension; 1993 Nov; 22(5):688-98. PubMed ID: 8225529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
    Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
    Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Converting enzyme inhibition improves congestion and survival in hypertensive rats with high-output heart failure.
    Nishimura H; Oka T; Ueyama M; Kubota J; Kawamura K
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):149-54. PubMed ID: 7511728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
    Shen YT; Wiedmann RT; Greenland BD; Lynch JJ; Grossman W
    Cardiovasc Res; 1998 Aug; 39(2):413-22. PubMed ID: 9798526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].
    Stumpe KO
    Klin Wochenschr; 1985 Sep; 63(18):897-906. PubMed ID: 2997540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blunted renal responses to angiotensin II infusion in lifetime captopril-treated spontaneously hypertensive rats.
    Wu JN; Tsai SY; Hsieh WY
    Chin J Physiol; 2001 Jun; 44(2):59-65. PubMed ID: 11530945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE).
    DeForrest JM; Waldron TL; Harvey C; Scalese R; Hammerstone S; Powell JR; Karanewsky D
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):121-7. PubMed ID: 1696654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of long-term oral captopril treatment on mesenteric blood flow in spontaneously hypertensive rats.
    Rozsa Z; Sonkodi S
    Pharmacol Res; 1995; 32(1-2):21-5. PubMed ID: 8668643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
    van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
    J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential pressor and renal vascular reactivity to angiotensin II in spontaneously hypertensive and Wistar-Kyoto rats.
    Guidi E; Hollenberg NK
    Hypertension; 1987 Jun; 9(6):591-7. PubMed ID: 3294592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats.
    Unger T; Kaufmann-Bühler I; Schölkens B; Ganten D
    Eur J Pharmacol; 1981 Apr; 70(4):467-78. PubMed ID: 6263638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibition. Systemic and regional hemodynamics in rats and humans.
    Giudicelli JF; Richer C; Richard C; Thuillez C
    Am J Hypertens; 1991 Mar; 4(3 Pt 2):258S-262S. PubMed ID: 2043315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired renal vascular response to a D1-like receptor agonist but not to an ACE inhibitor in conscious spontaneously hypertensive rats.
    de Vries PA; Navis G; de Jong PE; de Zeeuw D; Kluppel CA
    J Cardiovasc Pharmacol; 1999 Aug; 34(2):191-8. PubMed ID: 10445669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of renin inhibition compared to angiotensin converting enzyme inhibition in conscious dogs with pacing-induced heart failure.
    Shannon RP; Friedrich S; Mathier M; Knight DR
    Cardiovasc Res; 1997 Jun; 34(3):464-72. PubMed ID: 9231029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of angiotensin converting enzyme and renin inhibition in rats following myocardial infarction.
    Mento PF; Maita ME; Murphy WR; Holt WF; Wilkes BM
    J Cardiovasc Pharmacol; 1993 May; 21(5):791-6. PubMed ID: 7685451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.